Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries von Kandolf Sekulovic, L., Guo, J., Agarwala, S., Hauschild, A., McArthur, G., Cinat, G., Wainstein, A., Caglevic, C., Lorigan, P., Gogas, H., Alvarez, M., Duncombe, R., Lebbe, C., Peris, K., Rutkowski, P., Stratigos, A., Forsea, A.-M., De La Cruz Merino, L., Kukushkina, M., Dummer, R., Hoeller, C., Gorry, C., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Arenberger, P., Bylaite-Bucinskiene, M., Babovic, N., Banjin, M., Putnik, K., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Ymeri, A., Stojkovski, I., Garbe, C.

Volltext

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant von Neven, P, Fasching, P A, Chia, S, Jerusalem, G, De Laurentiis, M, Im, S-A, Petrakova, K, Bianchi, G V, Martín, M, Nusch, A, Sonke, G S, De la Cruz-Merino, L, Beck, J T, Zarate, J P, Wang, Y, Chakravartty, A, Wang, C, Slamon, D J

Volltext

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III rando... von Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Petrakova, K., Valeria Bianchi, G., Martín, M., Nusch, A., Sonke, G.S., De la Cruz-Merino, L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.

Volltext

Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study von de la Cruz-Merino, L, Gion, M, Cruz, J, Alonso-Romero, JL, Quiroga, V, Moreno, F, Andrés, R, Santisteban, M, Ramos, M, Holgado, E, Cortés, J, López-Miranda, E, Cortés, A, Henao, F, Palazón-Carrión, N, Rodriguez, L. M, Ceballos, I, Soto, A, Puertes, A, Casas, M, Benito, S, Chiesa, M, Bezares, S, Caballero, R, Jiménez-Cortegana, C, Sánchez-Margalet, V, Rojo, F

Volltext

SEOM clinical guidelines in advanced and recurrent breast cancer (2018) von Chacón López-Muñiz, J. I., de la Cruz Merino, L., Gavilá Gregori, J., Martínez Dueñas, E., Oliveira, M., Seguí Palmer, M. A., Álvarez López, I., Antolin Novoa, S., Bellet Ezquerra, M., López-Tarruella Cobo, S.

Volltext

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments von Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, J.-J, Nathan, P, Dummer, R, Forsea, A.-M, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M, Garbe, C

Volltext

nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from t... von Yardley, D.A., Coleman, R., Conte, P., Cortes, J., Brufsky, A., Shtivelband, M., Young, R., Bengala, C., Ali, H., Eakel, J., Schneeweiss, A., de la Cruz-Merino, L., Wilks, S., O’Shaughnessy, J., Glück, S., Li, H., Miller, J., Barton, D., Harbeck, N.

Volltext

Development of a leakage monitoring system in isolated limb perfusion with portable gamma camera von Agudo Martínez, A, Calvo Morón, C, Cambil Molina, T, García Gómez, F J, de la Riva Pérez, P A, de la Cruz Merino, L, Araji Tiliani, O, Terrón León, J A, Castro Montaño, J

Volltext

Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER) von Albanell, J., Martínez, M.T., Ramos, M., O'Connor, M., de la Cruz-Merino, L., Santaballa, A., Martínez-Jañez, N., Moreno, F., Fernández, I., Alarcón, J., Virizuela, J.A., de la Haba-Rodríguez, J., Sánchez-Rovira, P., González-Cortijo, L., Margelí, M., Sánchez-Muñoz, A., Antón, A., Casas, M., Bezares, S., Rojo, F.

Volltext

Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis von Piulats, J.M., Watkins, C., Costa-García, M., del Carpio, L., Piperno-Neumann, S., Rutkowski, P., Hassel, J.C., Espinosa, E., de la Cruz-Merino, L., Ochsenreither, S., Shoushtari, A.N., Orloff, M., Salama, A.K.S., Goodall, H.M., Baurain, J.-F., Nathan, P.

Volltext

Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice von Pérez-Ruiz, E., Jiménez-Castro, J., Berciano-Guerrero, M.-A., Valdivia, J., Estalella-Mendoza, S., Toscano, F., Rodriguez de la Borbolla Artacho, M., Garrido-Siles, M., Martínez-Bautista, M. J., Villatoro Roldan, R., Rivas-Ruiz, F., Nogales-Fernández, E., Morales, C., Pérez-Valderrama, B., De la Cruz-Merino, L., Rueda, A.

Volltext

SEOM clinical guideline for the management of cutaneous melanoma (2020) von Majem, M., Manzano, J. L., Marquez-Rodas, I., Mujika, K., Muñoz-Couselo, E., Pérez-Ruiz, E., de la Cruz-Merino, L., Espinosa, E., Gonzalez-Cao, M., Berrocal, A.

Volltext

2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary von Losa, F., Iglesias, L., Pané, M., Sanz, J., Nieto, B., Fusté, V., de la Cruz-Merino, L., Concha, Á., Balañá, C., Matías-Guiu, X.

Volltext

Corrigendum to ‘Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the... von Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Petrakova, K., Valeria Bianchi, G., Martín, M., Nusch, A., Sonke, G.S., De la Cruz-Merino, L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.

Volltext

SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma von Rueda Domínguez, A., Alfaro Lizaso, J., de la Cruz Merino, L., Gumá i Padró, J., Quero Blanco, C., Gómez Codina, J., Llanos Muñoz, M., Martinez Banaclocha, N., Rodriguez Abreu, D., Provencio Pulla, M.

Volltext

LENALIDOMIDE PLUS R‐GDP (R2‐GDP) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA. PRELIMINARY RESULTS OF THE R2‐GDP‐GOTEL TRIAL von Cruz‐Merino, L., Martín García‐Sancho, A., Nogales Fernández, E., Carnicero González, F., Ríos Herranz, E., Cruz Vicente, F., Rodríguez García, G., Nicolás García, C., Martínez Benaclocha, N., Gumà Padrò, J., Gómez Codina, J., Salar Silvestre, A., Rodríguez Abreu, D., Quero Blanco, C., Labrador Gómez, J., Guirado Risueño, M., Provencio Pulla, M., Rueda Domínguez, A.

Volltext

Phase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962) von Piulats Rodriguez, J.M., De La Cruz Merino, L., Espinosa, E., Alonso Carrión, L., Martin Algarra, S., López-Castro, R., Curiel García, M.T., Rodriguez Abreu, D., Rullan Iriarte, A.J., Berrocal Jaime, A.

Volltext

SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019) von Majem, M., García-Martínez, E., Martinez, M., Muñoz-Couselo, E., Rodriguez-Abreu, D., Alvarez, R., Arance, A., Berrocal, A., de la Cruz-Merino, L., Lopez-Martin, J. A.

Volltext

Myeloid derived-suppressor cells in healthy women and in advanced breast cancer patients von Palazón Carrión, N., Sánchez León, M.L., Jiménez Cortegana, C., Valdivia García, F.J., Araujo Fernández, I., Henao Carrasco, F., Nieto García, M.A., Sánchez Margalet, V., de la Cruz Merino, L.

Volltext

The complexity of cancer immunotherapy illustrated through skin tumors von Vieco-Martí, I., López-Carrasco, A., de la Cruz-Merino, L., Noguera, R., Álvaro Naranjo, T.

Volltext